Risk factors affecting vaccine efficacy against COVID-19 identified from 290 cross-country observational studies through February 2022: a meta-analysis and meta-regression

  • Hasan T, Beardsley J, Marais BJ, Nguyen TA, Fox GJ. The implementation of mass vaccination against SARS-CoV-2: a systematic review of existing strategies and guidelines. vaccines 2021;9:326.

    CAS PubMed PubMed Central Google Scholar

  • Albert-Ludwigs-Universität Freiburg, Germany, Fortner A, Schumacher D, Department of Anesthesiology, RWTH Aachen University Hospital, Germany. The first COVID-19 vaccines to receive emergency use authorization from the US FDA and EMA. discoveries 2021;9:e122.

    Google Scholar

  • Mallapaty S. WHO approval of China’s CoronaVac COVID vaccine will be crucial to curb pandemic. Nature. 2021;594:161–2.

    CAS PubMed Google Scholar

  • Pormohammad A, Zarei M, Ghorbani S, Mohammadi M, Razizadeh MH, Turner DL, et al. Efficacy and safety of vaccines against COVID-19: a systematic review and meta-analysis of randomized clinical trials. vaccines 2021;9:467.

    CAS PubMed PubMed Central Google Scholar

  • Ling Y, Zhong J, Luo J. Safety and effectiveness of SARS-CoV-2 vaccines: a systematic review and meta-analysis. J Med Virol. 2021;93:6486–95.

    CAS PubMed PubMed Central Google Scholar

  • Henry DA, Jones MA, Stehlik P, Glasziou PP. Effectiveness of vaccines against COVID-19: results from real-world studies. Med J Aust. 2021;215:149.

    PubMed PubMed Central Google Scholar

  • Harder T, Koch J, Vygen-Bonnet S, Külper-Schiek W, Pilic A, Reda S, et al. Efficacy and effectiveness of COVID-19 vaccines against SARS-CoV-2 infection: interim results of a live systematic review, 1 January to 14 May 2021. Eurosurveillance. 2021;26:2100563.

  • Singh DD, Parveen A, Yadav DK. SARS-CoV-2: emergence of new variants and effectiveness of vaccines. Frontal Cell Infected Microbiol. 2021;11:777212.

    CAS PubMed PubMed Central Google Scholar

  • Hafiz I, Illian DN, Meila O, Utomo ARH, Susilowati A, Susetya IE, et al. Efficacy and effectiveness of mutated SARS-CoV-2 vaccine and post-vaccination surveillance: a narrative review. vaccines 2022;10:82.

    CAS PubMed PubMed Central Google Scholar

  • Jena A, James D, Singh AK, Dutta U, Sebastian S, Sharma V. Effectiveness and durability of COVID-19 vaccination in 9447 patients with IBD: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022;20:1456–1479.e18.

    CAS PubMed PubMed Central Google Scholar

  • Mohammed I, Nauman A, Paul P, Ganesan S, Chen KH, Jalil SMS, et al. The efficacy and effectiveness of COVID-19 vaccines in reducing infection, severity, hospitalization and mortality: a systematic review. Hum Immunother Vaccines. 2022;18:2027160.

    Google Scholar

  • Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int J Infect Dis. 2022;114:252–60.

    CAS PubMed Google Scholar

  • Harder T, Külper-Schiek W, Reda S, Treskova-Schwarzbach M, Koch J, Vygen-Bonnet S, et al. Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta variant (B.1.617.2): according to interim results of a systematic review and live meta-analysis, January 1-25 August 2021. Eurosurveillance. 2021;26:2100920.

  • Tatsi EB, Filippatos F, Michos A. SARS-CoV-2 variants and vaccine effectiveness: a review of current evidence. Epidemiol infection. 2021;149:e237.

    CAS PubMed Google Scholar

  • Chuenkitmongkol S, Solante R, Burhan E, Chariyalertsak S, Chiu NC, Do-Van D, et al. Expert review of the overall effectiveness of the SARS-CoV-2 vaccine. Expert Rev Vaccines. 2022;21:1255–68.

    PubMed Google Scholar

  • Di Fusco M, Lin J, Vaghela S, Lingohr-Smith M, Nguyen JL, Scassellati Sforzolini T, et al. Effectiveness of the COVID-19 vaccine among immunocompromised populations: a literature review targeting real-world studies. Expert Rev Vaccines. 2022;21:435–51.

    PubMed Google Scholar

  • Chandan S, Khan SR, Deliwala S, Mohan BP, Ramai D, Chandan OC, et al. Post-vaccination SARS-CoV-2 infection among healthcare workers: a systematic review and meta-analysis. J Med Virol. 2022;94:1428–41.

    CAS PubMed Google Scholar

  • Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, et al. Duration of vaccine effectiveness against SARS-CoV-2 infection and COVID-19 disease: results from a systematic review and meta-regression. Lancet. 2022;399:924–44.

    CAS PubMed PubMed Central Google Scholar

  • Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations for boosting immune responses to the COVID-19 vaccine. Lancet 2021;398:1377–80.

    CAS PubMed PubMed Central Google Scholar

  • Mahase E. Covid-19 booster vaccines: what we know and who is doing what. BMJ. 2021;374:n2082.

  • PRISMA-S Group, Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, et al. PRISMA-S: an extension of the PRISMA Statement for reporting literature searches in systematic reviews. System Rev. 2021; 10:39.

    Google Scholar

  • Moher D, Liberati A, Tetzlaff J, Altman DG. The PRISMA Group. Preferred reporting elements for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.

    PubMed PubMed Central Google Scholar

  • Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

  • Stroup DF. Meta-analysis of observational studies in epidemiology: a proposal for a report. JAMA. 2000;283:2008.

    CAS PubMed Google Scholar

  • Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses; 2000

    Google Scholar

  • Xie S, Xu H, Shan X, Liu B, Wang K, Cai Z. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis. PLoS One. 2015;10:e0116517.

    PubMed PubMed Central Google Scholar

  • Higgins JPT. Measurement inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    PubMed PubMed Central Google Scholar

  • Chaimani A, Mavridis D, Salanti G. A practical tutorial on performing meta-analysis with Stata. Evidence-Based Mental Health. 2014;17:111–6.

    PubMed Google Scholar

  • Herzog R, Álvarez-Pasquin MJ, Díaz C, Del Barrio JL, Estrada JM, Gil Á. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review. BMC Public Health. 2013;13:154.

    PubMed PubMed Central Google Scholar

  • Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE Guidelines: 1. Introduction: GRADE Evidence Profiles and Summary of Findings Tables. J Clin Epidemiol. 2011;64:383–94.

    PubMed Google Scholar

  • Harbord RM, Egger M, Sterne JAC. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Medical Statistics 2006;25:3443–57.

    PubMed Google Scholar

  • Krause P, Fleming TR, Longini I, Henao-Restrepo AM, Peto R, Dean N, et al. Trials of the vaccine against COVID-19 should look for worthwhile efficacy. Lancet. 2020;396:741–3.

    CAS PubMed PubMed Central Google Scholar

  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 Covid-19 mRNA vaccine. N Engl J Med. 2020;383:2603–15.

    CAS PubMed Google Scholar

  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.

    CAS PubMed Google Scholar

  • Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomized controlled trials in Brazil, South Africa and the United Kingdom. Lancet. 2021;397:99–111.

    CAS PubMed PubMed Central Google Scholar

  • Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of the Ad26.COV2.S single-dose vaccine against Covid-19. N Engl J Med. 2021;384:2187–201.

    CAS PubMed Google Scholar

  • Britton A, Fleming-Dutra KE, Shang N, Smith ZR, Dorji T, Derado G, et al. Association of COVID-19 vaccination with symptomatic SARS-CoV-2 infection by time since vaccination and delta variant predominance. JAMA. 2022;327:1032.

    CAS PubMed PubMed Central Google Scholar

  • Tartof SY, Slezak JM, Puzniak L, Hong V, Frankland TB, Ackerson BK, et al. Efficacy of a third dose of BNT162b2 COVID-19 mRNA vaccine in a large US health system: a retrospective cohort study. Lancet Reg Health – Am. 2022;9:100198.

    PubMed PubMed Central Google Scholar

  • Abu-Raddad LJ, Chemaitelly H, Bertollini R. Waning mRNA-1273 vaccine effectiveness against SARS-CoV-2 infection in Qatar. N Engl J Med….

  • Leave a Comment

    Your email address will not be published. Required fields are marked *